Organotypic models in drug development (2021)
Unidade: FCFSubjects: NEOPLASIAS, RESISTÊNCIA MICROBIANA ÀS DROGAS, PLANEJAMENTO DE FÁRMACOS, TESTES DE SENSIBILIDADE MICROBIANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Organotypic models in drug development. . Cham: Springer. Disponível em: https://doi.org/10.1007/978-3-030-70063-8. Acesso em: 11 set. 2024. , 2021APA
Organotypic models in drug development. (2021). Organotypic models in drug development. Cham: Springer. doi:10.1007/978-3-030-70063-8NLM
Organotypic models in drug development [Internet]. 2021 ;[citado 2024 set. 11 ] Available from: https://doi.org/10.1007/978-3-030-70063-8Vancouver
Organotypic models in drug development [Internet]. 2021 ;[citado 2024 set. 11 ] Available from: https://doi.org/10.1007/978-3-030-70063-8